Forget $3: Could Aurora (TSX:ACB) Stock Drop to $0?

With a worrying recent announcement, there is a chance that Aurora stock might go down further to a point where you might want nothing to do with it.

| More on:
Economic Turbulence

Image source: Getty Images

Cannabis investors, beware: bad times are possibly on their way for Aurora Cannabis (TSX:ACB)(NYSE:ACB). Since Cannabis 1.0, the pot industry has declined drastically across the board. Aurora Cannabis is one of the major players in the marijuana sector on the TSX, and it might have worse on its way.

Bad news

Trading for $3.48 per share at writing, ACB stock is down by 74.62% from the record highs the company achieved right before the Cannabis 1.0 announcement. Aurora is one of the pot companies with plenty of assets to its name. The fact that there is no profitability in the legal weed sector, ACB had to rely on issuing shares to raise capital for those acquisitions.

In the stock market, the more shares you issue, the more the shareholder wealth gets diluted. The company already has over one billion shares trading on the stock market. The past Monday saw ACB announce that its holders have sent them a notice to convert the unsecured convertible debenture debt into equity for them.

According to ACB, the 5% convertible debentures are worth $277 million. The conversion of the debentures into equity will take place for $3.2837 per share. Based on the amount and the price per share, ACB will have to issue an additional 69.13 million shares with a deadline for March 9, 2020.

The already diluted wealth has caused the share prices of ACB to plunge. Issuing more than 69 million more shares will not make things any better for the pot producer.

…it gets worse

The only ray of hope for Aurora and the overall cannabis industry is the sale of products legalized by Cannabis 2.0. If there is a strong demand for Cannabis 2.0 products, it can open up a new revenue generation stream for Aurora Cannabis. Hopefully, this revenue stream will not get bogged down by the illegal sector with the competition.

Enter the United States Food and Drugs Administration (FDA). The FDA has released a detailed report that concerns all the safety issues related to CBD products. The governing body in the U.S. claims that there is a lack of evidence to support that CBD products are safe for consumption.

The cannabis sector was rattled by the CannTrust scandal because the company was growing unregulated strands of weed without regard to regulation. Reports like the one issued by a significant governing body can become the final nail in the coffin for companies that are already struggling.

Foolish takeaway

I want to say that my verdict on ACB is like the flip of a coin at 50/50. There’s the fact that a strong demand for Cannabis 2.0 can potentially send ACB stocks skyrocketing. Between the March deadline to convert unsecured convertible debentures into equity for its holders and the impact of health concerns on demands, I think the situation is not favourable for ACB.

I would be wary of ACB stock, but in the off chance it takes off, the sky is the limit for Aurora stock in the long run.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »